发明名称 MARKERS OF ALZHEIMERS DISEASE
摘要 An inflammatory process is suggested to be involved in the pathogenesis of Alzheimer's disease (AD), a neurodegenerative disorder characterized by the presence of neuritic plaques within the cerebral cortex that are mainly composed of a small insoluble protein of 40-42 aminoacids (amyloid protein). Amyloid-specific Interleukin-10 (IL-10) generation is found to be selectively and significantly reduced in AD patients (p=0.023). The genotype associated with high IL-10 production is extremely infrequent in AD individuals (2% vs. 28%). The presence of low/intermediate-IL-10-producing genotypes (GCC/ATA; ATA/ATA) was associated with an earlier age at disease onset and (ACC/ACC; ACC/ATA) with an accelerated rate of disease progression/severity and with amyloid-specific impairment of IL-10 production. This relationship is independent of ApoE gene polymorphism. These results support the use of anti-inflammatory compounds in the therapy of this disease.
申请公布号 US2014193440(A1) 申请公布日期 2014.07.10
申请号 US201414149362 申请日期 2014.01.07
申请人 ImmunoClin Ltd. 发明人 Clerici Mario;Annoni Giorgio;Arosio Beatrice
分类号 C12Q1/68 主分类号 C12Q1/68
代理机构 代理人
主权项
地址 London GB